Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-Jun-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 25)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
18-Jun-13 New Constructs, LLC N/A OPK: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
18-Jun-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical Instruments 17 $195.50 View Abstract
17-Jun-13 Alpha Street Research Hunter Orr OPK - Opko Health Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report 9 $24 View Abstract
17-Jun-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - OPKO HEALTH INCORPORATION (OPK-N) 11 $25 View Abstract
17-Jun-13 Pechala's Reports Lubomir Pechala OPKO HEALTH INC (OPK) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
15-Jun-13 S&P Capital IQ Quantitative Report N/A Opko Health 6 $69 View Abstract
15-Jun-13 Pechala's Reports Frantisek Pechala OPKO HEALTH INC (OPK) 12-months forecast 1 $15 View Abstract
14-Jun-13 Reuters Investment Profile N/A OPKO Health Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) 77 $885.50 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) 78 $897 View Abstract
Next 15

Independent Reports (Showing 1 to 10 of 25)

Release
Date Contributor Author Title Pages Price More Info
18-Jun-13 New Constructs, LLC N/A OPK: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
18-Jun-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical Instruments 17 $195.50 View Abstract
17-Jun-13 Alpha Street Research Hunter Orr OPK - Opko Health Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report 9 $24 View Abstract
17-Jun-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - OPKO HEALTH INCORPORATION (OPK-N) 11 $25 View Abstract
17-Jun-13 Pechala's Reports Lubomir Pechala OPKO HEALTH INC (OPK) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
15-Jun-13 S&P Capital IQ Quantitative Report N/A Opko Health 6 $69 View Abstract
15-Jun-13 Pechala's Reports Frantisek Pechala OPKO HEALTH INC (OPK) 12-months forecast 1 $15 View Abstract
14-Jun-13 Reuters Investment Profile N/A OPKO Health Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) 77 $885.50 View Abstract
14-Jun-13 Wright Reports N/A Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) 78 $897 View Abstract
Next 15

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.